Progress in the Treatment of Chronic Cough

doi:10.12114/j.issn.1007-9572.2021.00.113

Abstract

Abstract: As a common disease，chronic cough seriously affects the quality of life of patients，and its prevalence rate is as high as 12%.Nevertheless，there is a lack of effective treatment in clinic.This paper summarizes the classification，etiology and mechanism of chronic cough，reviews the existing and emerging treatment methods of chronic cough，and finds that targeted therapy and non-drug therapy are of great significance in improving the prognosis of patients with chronic cough.With the further development of targeted drugs and the further discovery of new treatment methods，the treatment of chronic cough is no longer without medicine available，but will tend to be precise and systematic.

Key words: Cough, Chronic cough, Physiotherapy, Language pathology, Targeted therapy

摘要： 慢性咳嗽作为一种常见的疾病患病率高达12%，其严重影响了患者的生活质量。尽管如此，目前临床上尚缺乏有效的治疗方式。本文总结了慢性咳嗽的分类、病因及机制，归纳了慢性咳嗽现有及新兴的治疗方式，发现针对咳嗽反射的靶向治疗以及非药物治疗对改善慢性咳嗽患者的预后有重大意义，提出随着靶向药物的进一步开发以及新型治疗方式的进一步发现，慢性咳嗽的治疗不再无药可用而将趋向精准体系化。

关键词: 咳嗽, 慢性咳嗽, 理疗, 语言病理治疗, 靶向治疗

赵凌云,李宏云. 慢性咳嗽的治疗新进展[J]. 中国全科医学, 2021, 24(8): 930-940. DOI: 10.12114/j.issn.1007-9572.2021.00.113.

References

［1］LANDT E，?OLAK Y，LANGE P，et al．Chronic cough in individuals with COPD：a population-based cohort study［J］．Chest，2020，157（6）：1446-1454．DOI：10.1016/j.chest.2019.12.038.
［2］GUILLEMINAULT L，BROUQUIèRES D，DIDIER A.From acute cough to chronic cough in adults：overview on a common reason for consultation［J］．Presse Med，2019，48（4）：353-364．DOI：10.1016/j.lpm.2019.02.009.
［3］SATIA I，BADRI H，AL-SHEKLLY B，et al．Towards understanding and managing chronic cough［J］．Clin Med（Lond），2016，16（Suppl 6）：s92-97．DOI：10.7861/clinmedicine.16-6-s92.
［4］PACHECO A，DE DIEGO A，DOMINGO C，et al．Chronic cough［J］．Arch De Bronconeumología Engl Ed，2015，51（11）：579-589．DOI：10.1016/j.arbr.2015.09.009.
［5］KANG S Y，WON H K，LEE S M，et al．Impact of cough and unmet needs in chronic cough：a survey of patients in Korea［J］．Lung，2019，197（5）：635-639．DOI：10.1007/s00408-019-00258-9.
［6］VAN MANEN M J G，WIJSENBEEK M S.Cough，an unresolved problem in interstitial lung diseases［J］．Curr Opin Support Palliat Care，2019，13（3）：143-151．DOI：10.1097/SPC.0000000000000447.
［7］PTAK K，CICHOCKA-JAROSZ E，KWINTA P.Chronic cough in children［J］．Dev Period Med，2018，22（4）：329-340.
［8］WON H K，KANG S Y，KANG Y，et al．Cough-related laryngeal sensations and triggers in adults with chronic cough：symptom profile and impact［J］．Allergy Asthma Immunol Res，2019，11（5）：622-631．DOI：10.4168/aair.2019.11.5.622.
［9］HHECHING M，ROSENGARTEN D，SHITENBERG D，et al．Bronchoscopy for chronic unexplained cough：use of biopsies and cultures increase diagnostic yield［J］．J Bronchology Interv Pulmonol，2020，27（1）：30-35．DOI：10.1097/LBR.0000000000000629
［10］GIBSON P，WANG G，MCGARVEY L，et al．Treatment of unexplained chronic cough：chest guideline and expert panel report［J］．Chest，2016，149（1）：27-44．DOI：10.1378/chest.15-1496.
［11］CHO P S P，FLETCHER H V，TURNER R D，et al．Impaired cough suppression in chronic refractory cough［J］．Eur Respir J，2019，53（5）：1802203．DOI：10.1183/13993003.02203-2018.
［12］LI J，YE L.Effect of pregabalin for the treatment of chronic refractory cough：a case report［J］．Medicine（Baltimore），2019，98（23）：e15916．DOI：10.1097/md.0000000000015916.
［13］DICPINIGAITIS P V，ENILARI O，CLEVEN K L.Prevalence of arnold nerve reflex in subjects with and without chronic cough：relevance to cough hypersensitivity syndrome［J］．Pulm Pharmacol Ther，2019，54：22-24．DOI：10.1016/j.pupt.2018.11.003.
［14］KELLER J A，MCGOVERN A E，MAZZONE S B.Translating cough mechanisms into better cough suppressants［J］．Chest，2017，152（4）：833-841．DOI：10.1016/j.chest.2017.05.016.
［15］MADISON J M，IRWIN R S.Chronic cough and COPD［J］．Chest，2020，157（6）：1399-1400．DOI：10.1016/j.chest.2020.02.012.
［16］SATO R，HANDA T，MATSUMOTO H，et al．Clinical significance of self-reported cough intensity and frequency in patients with interstitial lung disease：a cross-sectional study［J］．BMC Pulm Med，2019，19（1）：247．DOI：10.1186/s12890-019-1012-6.
［17］CHEN L C，ZENG G S，WU L L，et al．Diagnostic value of FeNO and MMEF for predicting cough variant asthma in chronic cough patients with or without allergic rhinitis［J］．J Asthma，2019：1-8．DOI：10.1080/02770903.2019.1694035.
［18］C?Té A，RUSSELL R J，BOULET L P，et al．Managing chronic cough due to asthma and NAEB in adults and adolescents：chest guideline and expert panel report［J］．Chest，2020，158（1）：68-96．DOI：10.1016/j.chest.2019.12.021
［19］PARK H J，PARK Y M，KIM J H，et al．Effectiveness of proton pump inhibitor in unexplained chronic cough［J］．PLoS One，2017，12（10）：e0185397．DOI：10.1371/journal.pone.0185397.
［20］CHEN X，PENG W S，WANG L.Etiology analysis of nonspecific chronic cough in children of 5 years and younger［J］．Medicine（Madr），2019，98（3）：e13910．DOI：10.1097/md.0000000000013910.
［21］XU M Z，LIU J Y，FU Z.Causes of chronic cough in children in Chongqing，China：an analysis of 202 cases［J］．Zhongguo Dang Dai Er Ke Za Zhi，2019，21（5）：436-440．DOI：10.7499/j.issn.1008-8830.2019.05.007.
［22］KANTAR A，SEMINARA M.Why chronic cough in children is different［J］．Pulm Pharmacol Ther，2019，56：51-55．DOI：10.1016/j.pupt.2019.03.001.
［23］LUCANSKA M，HAJTMAN A，CALKOVSKY V，et al．Upper airway cough syndrome in pathogenesis of chronic cough［J］．Physiol Res，2020：S35-42．DOI：10.33549/physiolres.934400.
［24］KARIYA S，OKANO M，HIGAKI T，et al．Long-term treatment with clarithromycin and carbocisteine improves lung function in chronic cough patients with chronic rhinosinusitis［J］．Am J Otolaryngol，2020，41（1）：102315．DOI：10.1016/j.amjoto.2019.102315.
［25］JAMSHED F，JAFFRY H，HANIF H，et al．Demographic and clinical characteristics of patients presenting with angiotensin-converting enzyme inhibitors induced cough［J］．Cureus，2019，11（9）：e5624．DOI：10.7759/cureus.5624.
［26］TOS-RYCHARSKA E，WASIELEWSKA Z，NADOLSKA K，
et al．A foreign body in the mediastinum as a cause of chronic cough in a 10-year-old child with asthma［J］．J Asthma，2019：1-5．DOI：10.1080/02770903.2019.1684515.
［27］TZILAS V，KYRIAZIS P，TZOUVELEKIS A，et al．A 63-year-old woman with pulmonary micronodules and chronic cough［J］．Chest，2019，156（2）：e47-50．DOI：10.1016/j.chest.2019.03.034.
［28］CINELLI E，IOVINO L，BONGIANNI F，et al．GABAA-and glycine-mediated inhibitory modulation of the cough reflex in the caudal nucleus tractus solitarii of the rabbit［J］．Am J Physiol Lung Cell Mol Physiol，2016，311（3）：L570-580．DOI：10.1152/ajplung.00205.2016.
［29］AL-SHAMLAN F，EL-HASHIM A Z.Bradykinin sensitizes the cough reflex via a B2 receptor dependent activation of TRPV1 and TRPA1 channels through metabolites of cyclooxygenase and 12-lipoxygenase［J］．Respir Res，2019，20（1）：110．DOI：10.1186/s12931-019-1060-8.
［30］LONG L，YAO H，TIAN J，et al．Heterogeneity of cough hypersensitivity mediated by TRPV1 and TRPA1 in patients with chronic refractory cough［J］．Respir Res，2019，20（1）：112．DOI：10.1186/s12931-019-1077-z.
［31］XU X，CHEN Q，QIU Z，et al．Association of cough hypersensitivity with tracheal TRPV1 activation and neurogenic inflammation in a novel Guinea pig model of citric acid-induced chronic cough［J］．J Int Med Res，2018，46（7）：2913-2924．DOI：10.1177/0300060518778951.
［32］MILLQVIST E.TRPV1 and TRPM8 in treatment of chronic cough［J］．Pharmaceuticals（Basel），2016，9（3）：45．DOI：10.3390/ph9030045
［33］BEVAN S，QUALLO T，ANDERSSON D A.TRPV1［J］．Handb Exp Pharmacol，2014，222（3）：207-245．DOI：10.1007/978-3-642-54215-2_9.
［34］BUDAY T，KOVACIKOVA L，RUZINAK R，et al．TRPV4 antagonist GSK2193874 does not modulate cough response to osmotic stimuli［J］．Respir Physiol Neurobiol，2017，236：1-4．DOI：10.1016/j.resp.2016.10.010.
［35］BONVINI S J，BIRRELL M A，GRACE M S，et al．Transient receptor potential cation channel，subfamily V，member 4 and airway sensory afferent activation：role of adenosine triphosphate［J］．J Allergy Clin Immunol，2016，138（1）：249-261.e12．DOI：10.1016/j.jaci.2015.10.044.
［36］BONVINI S J，BELVISI M G.Cough and airway disease：the role of ion channels［J］．Pulm Pharmacol Ther，2017，47：21-28．DOI：10.1016/j.pupt.2017.06.009.
［37］DICPINIGAITIS P V，MCGARVEY L P，CANNING B J.P2X3-receptor antagonists as potential antitussives：summary of current clinical trials in chronic cough［J］．Lung，2020，198（4）：609-616．DOI：10.1007/s00408-020-00377-8.
［38］MUCCINO D，GREEN S.Update on the clinical development of gefapixant，a P2X3 receptor antagonist for the treatment of refractory chronic cough［J］．Pulm Pharmacol Ther，2019，56：75-78．DOI：10.1016/j.pupt.2019.03.006.
［39］MORICE A H，MILLQVIST E，BIEKSIENE K，et al．ERS guidelines on the diagnosis and treatment of chronic cough in adults and children［J］．Eur Respir J，2020，55（1）：1901136．DOI：10.1183/13993003.01136-2019.
［40］CHUNG K F，MCGARVEY L，MAZZONE S B.Chronic cough as a neuropathic disorder［J］．Lancet Respir Med，2013，1（5）：414-422．DOI：10.1016/s2213-2600（13）70043-2.
［41］BIRRING S S，FLOYD S，REILLY C C，et al．Physiotherapy and speech and language therapy intervention for chronic cough［J］．Pulm Pharmacol Ther，2017，47：84-87．DOI：10.1016/j.pupt.2017.04.001.
［42］DRIESSEN A K，DEVLIN A C，LUNDY F T，et al．Perspectives on neuroinflammation contributing to chronic cough［J］．Eur Respir J，2020：2000758．DOI：10.1183/13993003.00758-2020.
［43］DING H，XU X，WEN S，et al．Changing etiological frequency of chronic cough in a tertiary hospital in Shanghai，China［J］．J Thorac Dis，2019，11（8）：3482-3489．DOI：10.21037/jtd.2019.07.86.
［44］VERTIGAN A E.Chronic cough：prevention is better than cure［J］．Lancet Child Adolesc Health，2019，3（12）：840-842．DOI：10.1016/S2352-4642（19）30322-0.
［45］KANG S Y，SONG W J，WON H K，et al．Cough persistence in adults with chronic cough：a 4-year retrospective cohort study［J］．Allergol Int，2020，69（4）：588-593．DOI：10.1016/j.alit.2020.03.012.
［46］LAMON T，DIDIER A，BROUQUIèRES D，et al．Exhaled nitric oxide in chronic cough：a good tool in a multi-step approach［J］．Respir Med Res，2019，76：4-9．DOI：10.1016/j.resmer.2019.04.005.
［47］CREWS K R，GAEDIGK A，DUNNENBERGER H M，et al．Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy：2014 update［J］．Clin Pharmacol Ther，2014，95（4）：376-382．DOI：10.1038/clpt.2013.254.
［48］GARDINER S J，CHANG A B，MARCHANT J M，et al．Codeine versus placebo for chronic cough in children［J］．Cochrane Database Syst Rev，2016，7（7）：D11914．DOI：10.1002/14651858.CD011914.pub2.
［49］AL-SHEKLLY B，MITCHELL J，ISSA B，et al．Randomised control trial quantifying the efficacy of low dose morphine in a responder group of patients with refractory chronic cough［J］．Thorax，2017，72（Suppl 3）：A24．DOI：10.1136/thoraxjnl-2017-210983.41.
［50］RYAN N M，BIRRING S S，GIBSON P G.Gabapentin for refractory chronic cough：a randomised，double-blind，placebo-controlled trial［J］．Lancet，2012，380（9853）：1583-1589．DOI：10.1016/s0140-6736（12）60776-4.
［51］VERTIGAN A E，KAPELA S L，RYAN N M，et al．Pregabalin and speech pathology combination therapy for refractory chronic cough［J］．Chest，2016，149（3）：639-648．DOI：10.1378/chest.15-1271.
［52］ANITA JEYAKUMAR M D，BRICKMAN T M，MICHAEL HABEN M D.Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy［J］．Laryngoscope，2010，116（12）：2108-2112．DOI：10.1097/01.mlg.0000244377.60334.e3.
［53］FOWLES H E，ROWLAND T，WRIGHT C，et al．Tussive challenge with ATP and AMP：does it reveal cough hypersensitivity?［J］．Eur Respir J，2017，49（2）：1601452．DOI：10.1183/13993003.01452-2016.
［54］FORD A P.In pursuit of P2X3 antagonists：novel therapeutics for chronic pain and afferent sensitization［J］．Purinergic Signal，2012，8（suppl 1）：3-26．DOI：10.1007/s11302-011-9271-6.
［55］ABDULQAWI R，DOCKRY R，HOLT K，et al．P2X3 receptor antagonist（AF-219）in refractory chronic cough：a randomised，double-blind，placebo-controlled phase 2 study［J］．Lancet，2015，385（9974）：1198-1205．DOI：10.1016/S0140-6736（14）61255-1.
［56］SMITH J A，KITT M M，MORICE A H，et al．Gefapixant，a P2X3 receptor antagonist，for the treatment of refractory or unexplained chronic cough：a randomised，double-blind，controlled，parallel-group，phase 2b trial［J］．Lancet Respir Med，2020，8（8）：775-785．DOI：10.1016/S2213-2600（19）30471-0.
［57］GARCEAU D，CHAURET N.BLU-5937：a selective P2X3 antagonist with potent anti-tussive effect and no taste alteration［J］．Pulm Pharmacol Ther，2019，56：56-62．DOI：10.1016/j.pupt.2019.03.007.
［58］GRONEBERG D A，NIIMI A，DINH Q T，et al．Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough［J］．Am J Respir Crit Care Med，2004，170（12）：1276-1280．DOI：10.1164/rccm.200402-174OC.
［59］MCLEOD R L，FERNANDEZ X，CORRELL C C，et al．TRPV1 antagonists attenuate antigen-provoked cough in ovalbumin sensitized guinea pigs［J］．Cough，2006，2：10．DOI：10.1186/1745-9974-2-10.
［60］KHALID S，MURDOCH R，NEWLANDS A，et al．Transient receptor potential vanilloid 1（TRPV1）antagonism in patients with refractory chronic cough：a double-blind randomized controlled trial［J］．J Allergy Clin Immunol，2014，134（1）：56-62．DOI：10.1016/j.jaci.2014.01.038.
［61］BELVISI M G，BIRRELL M A，WORTLEY M A，et al．XEN-D0501，a novel transient receptor potential vanilloid 1 antagonist，does not reduce cough in patients with refractory cough［J］．Am J Respir Crit Care Med，2017，196（10）：1255-1263．DOI：10.1164/rccm.201704-0769oc.
［62］PRETI D，SAPONARO G，SZALLASI A.Transient receptor potential ankyrin 1（TRPA1）antagonists［J］．Pharm Pat Anal，2015，4（2）：75-94．DOI：10.4155/ppa.14.60.
［63］LUDBROOK V J，HANROTT K E，MARKS-KONCZALIK J，
et al．A placebo-controlled，double-blind，randomised，crossover study to assess the efficacy，safety and tolerability of TRPV4 inhibitor GSK2798745 in participants with chronic cough［J］．Thorax，2019，74（Suppl 2）：A18．DOI：10.1136/thorax-2019-BTSabstracts2019.33.
［64］CANNING B J，MORI N，LEHMANN A.Antitussive effects of the peripherally restricted GABAB receptor agonist lesogaberan in Guinea pigs：comparison to baclofen and other GABAB receptor-selective agonists［J］．Cough，2012，8（1）：7．DOI：10.1186/1745-9974-8-7.
［65］SMITH J，ALLMAN D，BADRI H，et al．The neurokinin-1 receptor antagonist orvepitant is a novel antitussive therapy for chronic refractory cough［J］．Chest，2020，157（1）：111-118．DOI：10.1016/j.chest.2019.08.001.
［66］HARLE A S M，SMITH J A，MOLASSIOTIS A，et al．A placebo-controlled trial of aprepitant for cough in lung cancer［J］．J Clin Oncol，2015，33（29_suppl）：2．DOI：10.1200/jco.2015.33.29_suppl.2.
［67］MAHER S，BIRRELL M，BAKER K，et al．Cromoglycate：breathing life into an old asthma drug［J］．Eur Respir J，2015，46（suppl 59）：A1017．DOI：10.1183/13993003.congress-2015.PA1017.
［68］BIRRING S S，WIJSENBEEK M S，AGRAWAL S，et al．A novel formulation of inhaled sodium cromoglicate（PA101）in idiopathic pulmonary fibrosis and chronic cough：a randomised，double-blind，proof-of-concept，phase 2 trial［J］．Lancet Respir Med，2017，5（10）：806-815．DOI：10.1016/S2213-2600（17）30310-7.
［69］SARA，CLIVIO，ALESSANDRO，et al．Intravenous lidocaine for the prevention of cough：systematic review and Meta-analysis of randomized controlled trials［J］．Anesthesia and Analgesia，2018．DOI：10.1213/ANE.0000000000003699.
［70］CHAMBERLAIN MITCHELL S A F，GARROD R，CLARK L，et al．Physiotherapy，and speech and language therapy intervention for patients with refractory chronic cough：a multicentre randomised control trial［J］．Thorax，2017，72（2）：129-136．DOI：10.1136/thoraxjnl-2016-208843.
［71］CHAMBERLAIN S，GARROD R，BIRRING S S. Cough suppression therapy：does it work?[J]. Pulm Pharmacol Ther，2013，26（5）：524-527.DOI：?10.1016 / j.pupt.2013.03.012.
［72］PATEL A S，WATKIN G，WILLIG B，et al．Improvement in health status following cough-suppression physiotherapy for patients with chronic cough［J］．Chron Respir Dis，2011，8（4）：253-258．DOI：10.1177/1479972311422547.
［73］RYAN N M，VERTIGAN A E，BONE S，et al．Cough reflex sensitivity improves with speech language pathology management of refractory chronic cough［J］．Cough，2010，6：5．DOI：10.1186/1745-9974-6-5.
［74］RYAN N M，VERTIGAN A E，GIBSON P G.Chronic cough and laryngeal dysfunction improve with specific treatment of cough and paradoxical vocal fold movement［J］．Cough，2009，5（1）：4．DOI：10.1186/1745-9974-5-4.
［75］VERTIGAN A E，THEODOROS D G，GIBSON P G，et al．Efficacy of speech pathology management for chronic cough：a randomised placebo controlled trial of treatment efficacy［J］．Thorax，2006，61（12）：1065-1069．DOI：10.1136/thx.2006.064337.
［76］DICPINIGAITIS P，CANNING B，DEVITA R，et al．The antitussive effects of alpha7（α7）nicotinic receptor agonists［C］//Airway Pharmacology and Treatment.European Respiratory Society，2017.
［77］DICPINIGAITIS P V.Effect of tobacco and electronic cigarette use on cough reflex sensitivity［J］．Pulm Pharmacol Ther，2017，47：45-48．DOI：10.1016/j.pupt.2017.01.013.
［78］DICPINIGAITIS P V，LEE C A，Dicpinigaitis A J，et al．Effect of e-cigarette use on cough reflex sensitivity［J］．Chest，2016，149（1）：161-165．DOI：10.1378/chest.15-0817.
［79］SIMPSON C B，TIBBETTS K M，LOOCHTAN M J，et al．Treatment of chronic neurogenic cough with in-office superior laryngeal nerve block［J］．Laryngoscope，2018，128（8）：1898-1903．DOI：10.1002/lary.27201.
［80］XIE M R，ZHU Y F，ZHOU M Q，et al．Analysis of factors related to chronic cough after lung cancer surgery［J］．Thorac Cancer，2019，10（4）：898-903．DOI：10.1111/1759-7714.13021.
［81］GUILLEMINAULT L.Chronic cough and obesity［J］．Pulm Pharmacol Ther，2019，55：84-88．DOI：10.1016/j.pupt.2019.01.009.

[1]	NA Feiyang, YANG Yi, WANG Yong, WANG Yannan. Study on the Etiology of Chronic Cough in Children Aged 0-14 Years in Lanzhou from 2014 to 2023 [J]. Chinese General Practice, 2025, 28(24): 3026-3031.
[2]	RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960.
[3]	HU Lingxi, LI Mei, FU Yiwei, LU Lixia, MA Xiaoxuan, WANG Rongqi, NAN Yuemin. The Value of Serum VEGF in Evaluating the Clinical Efficacy of TACE Alone or Combined with Target Immunotherapy in Advanced Hepatocellular Carcinoma [J]. Chinese General Practice, 2024, 27(32): 4033-4039.
[4]	CHEN Chao, CHEN Tianxiang, LIU Qianwei, ZHANG Zhi, WANG Huanhuan, WU Pingping, GAO Lei, YU Zhaoxiang. Analysis and Identification of Hub Genes in Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network and Cancer Genome Atlas Clinical Data [J]. Chinese General Practice, 2024, 27(32): 4050-4059.
[5]	YI Shengguo, CAO Yedi, ZHAO Xue, LU Guizhi, ZHANG Yang, CONG Tiechuan, ZHANG Lanbo, ZHANG Jixin, LIANG Zhenwei, QU Chenxue, ZHANG Junqing, GAO Ying. EZH2 Expression in B Cell Lymphocyte Subsets of Hashimoto's Thyroiditis and the Therapeutic Mechanism and Effect of Its Inhibitors [J]. Chinese General Practice, 2024, 27(21): 2639-2645.
[6]	KANG Yinnan, SHI Jiaqi, WANG Junke, LI Bin, LI Chuyi, MA Jun, YU Xiaohui. Advances in the Application of Antibody Drug Conjugate in Gastric Cancer with Low Expression of Human Epidermal Growth Factor Receptor 2 [J]. Chinese General Practice, 2024, 27(18): 2287-2294.
[7]	PEI Bei, CHENG Lin, XU Lingyun. Effects of Different Neoadjuvant Chemotherapy Regimens on Immune Indicators and Tumor Microenvironment in HER-2-positive Breast Cancer Patients [J]. Chinese General Practice, 2023, 26(27): 3435-3440.
[8]	LIU Taotao, LI Tianrong, WANG Xue, CHEN Jiameng, SHUAI Zhiqin, LI Lisheng, XU Shangfu. Nanoparticle- and Exosome-based Targeted Drug Delivery Systems Used in the Diagnosis and Treatment of Atherosclerosis: Opportunities and Challenges [J]. Chinese General Practice, 2023, 26(08): 903-910.
[9]	WANG Jun, ZHANG Dong, FENG Zhenzhen, ZHANG Shujuan, ZHAO Guixiang, ZHANG Hailong, LI Jiansheng. Literature-based Research on Common Syndromes of Cough Variant Asthma [J]. Chinese General Practice, 2023, 26(03): 321-328.
[10]	LAO Shen, HE Jianxing, LIANG Wenhua. Targeting Pericytes for Vascular Normalization as an Emerging Strategy in Remodeling Tumor Microenvironment [J]. Chinese General Practice, 2022, 25(32): 3971-3977.
[11]	Ziqiang HONG, Dacheng JIN, Xiangdou BAI, Baiqiang CUI, Yunjiu GOU. Recent Advances in the Diagnosis and Management of Multiple Primary Lung Cancer [J]. Chinese General Practice, 2022, 25(27): 3435-3442.
[12]	SONG Yuzhi，ZHEN Chanjun，BAI Wenwen，LI Bo，QIAO Xueying，ZHOU Zhiguo. Intracranial Failure Analysis in Patients with Brain Metastasis from Lung Adenocarcinoma Harboring Epidermal Growth Factor Receptor Mutation　 [J]. Chinese General Practice, 2021, 24(29): 3704-3710.
[13]	CHEN Kai，LIANG Cuifei. Diagnostic Strategies for Cough in General Practice　 [J]. Chinese General Practice, 2021, 24(13): 1707-1710.
[14]	XIN Qingfeng，SUN Youli，KANG Meiqing，LI Chaoyan. Efficacy and Delay of Recurrence in Cough Variant Asthma Patients Treated with Salmeterol/Fluticasone　 [J]. Chinese General Practice, 2020, 23(26): 3280-3285.
[15]	TAN Wei，YANG Guili，HUANG Zhaolan. Interpretation of Guidelines for Primary Care of Cough 2018 in China from the Perspective of General Practice　 [J]. Chinese General Practice, 2019, 22(33): 4035-4040.